Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies
The application of mesenchymal stromal cells (MSCs) from different sources, including bone marrow (BM, bmMSCs), adipose tissue (atMSCs), and human term placenta (hPSCs) has been proposed for various clinical purposes. Accumulated evidence suggests that the activity of the different MSCs is indirect...
Main Authors: | Raphael Gorodetsky, Wilhelm K. Aicher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/10/5302 |
Similar Items
-
Mesenchymal Stromal Cells
by: Stanisław Szala, et al.
Published: (2014-11-01) -
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01) -
From Mesenchymal Stromal Cells to Engineered Extracellular Vesicles: A New Therapeutic Paradigm
by: Jancy Johnson, et al.
Published: (2021-07-01) -
Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses
by: Miguel Espina, et al.
Published: (2016-03-01) -
Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy
by: Amina Mohammadalipour, et al.
Published: (2020-12-01)